Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Invertin Biotechnology is a synthetic biology company specializing in the discovery, engineering, and manufacturing of high-performance enzymes. Headquartered in Hangzhou, China, the company utilizes a proprietary high-throughput screening and directed evolution platform to develop biocatalysts for diverse applications in molecular diagnostics and pharmaceutical manufacturing. Their product portfolio includes essential enzymes for PCR, NGS, and isothermal amplification, as well as customized solutions for green chemistry and biocatalysis. By integrating advanced protein engineering with large-scale fermentation, Invertin provides critical raw materials to the global life sciences and healthcare sectors. The company is recognized for its ability to rapidly evolve enzymes with enhanced stability, activity, and specificity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Invertin Biotechnology.